Report No. 23/2026 Resolutions adopted by the Ordinary General Meeting of Shareholders on 7 July 2026, together with information on the adjournment of the meeting until 16 July 2026 at 10:30 a.m.

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer”, the “Company”) hereby publishes, as an attachment to this current report, the resolutions adopted by the Ordinary General Meeting of Shareholders (the “OGM”), which was resumed on 7 July 2026 following the adjournment announced on 23 June 2026, together […]

Report No. 22/2026 List of Shareholders Holding at Least 5% of the Total Voting Rights at the Ordinary General Meeting Following the Resumption of Proceedings on 7 July 2026 Until the Announcement of a Recess in the Meeting

_MACHINE TRANSLATION_ The Management Board of Bioceltix S.A. with its registered office in Wrocław (the “Issuer” or the “Company”) hereby provides the list of shareholders who, at the Ordinary General Meeting of the Issuer (the “OGM”), held on 7 July 2026 and continued following the recess announced on 23 June 2026 until the announcement of […]